We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NovaLead Pharma

News List

NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug expresspharma
May 15, 2020
In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown better viral inhibition ability than Remdesivir, Fevipiravir, Hydroxychloroquine, Lopinavir/Ritonavir etc.
Computational methodologies can be effective in predicting and prioritising key targets related to COVID expresspharma
April 14, 2020
NovaLead Pharma, a Pune-based company has utilised its experience of drug repurposing has deployed computational technology to identify 42 existing drugs which may be potentially effective against the SARS-Cov2 virus.